Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
NCT00183989Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Aug 2000
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, mitoxantrone, rituximab in mantle cell lymphoma (MCL), sponsored by University of Southern California. Started Aug 2000; status: terminated.
02
Drugs
fludarabinemitoxantronerituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00183989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183989.